Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2Phase 3 Interventional

BioFreedom US IDE Feasibility Trial

ClinicalTrials.gov ID: NCT02131142

Public ClinicalTrials.gov record NCT02131142. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

To Collect Additional Safety and Effectiveness Data for the Biosensors BioFreedom™ BA9 Drug Coated Coronary Stent in Patients With Native, de Novo Coronary Artery Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to collect additional safety and effectiveness data for on the Biosensors BioFreedom™ BA9 Drug Coated Coronary Stent in patients with native, de novo coronary artery disease.

Study identification

NCT ID
NCT02131142
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Biosensors Europe SA
Industry
Enrollment
72 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2014 (Type not available)
Primary completion
Aug 2015 (Estimated)
Completion
Jul 2019 (Estimated)
Last update posted
Apr 1, 2015

2014 – 2019

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
MedStar Washington Hospital Center Washington D.C. District of Columbia 20010 —
Baptist Cardiac & Vascular Institute Miami Florida 33176 —
Emory University Hospital Atlanta Georgia 30322 —
Jewish Hospital and Saint Mary's Healthcare Louisville Kentucky 40202 —
MedStar Union Memorial Hospital Baltimore Maryland 21218 —
MedStar Southern Maryland Hospital Center Clinton Maryland 20735 —
Cardiac & Vascular Research Center of Northern Michigan Petoskey Michigan 49770 —
Our Lady of Lourdes Medical Center Voorhees Township New Jersey 08043 —
Columbia University Medical Center New York New York 10032, —
NC Heart and Vascular Research-Rex Hospital Raleigh North Carolina 27607 —
The Carl & Edyth Lindner Center for Research Cincinnati Ohio 45219 —
Mercy St. Vincent Medical Center Toledo Ohio 43608 —
Berks Cardiology Wyomissing Pennsylvania 19610 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02131142, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2015 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02131142 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →